Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix in the United Kingdom

Trial Profile

Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix in the United Kingdom

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2014

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 06 Feb 2014 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrial.gov record.
    • 05 Jul 2013 Planned End Date changed from 1 Feb 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 08 Feb 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top